Papers - The Globalization of Innovation: Pharmaceuticals

CHOOSE A PAPER ----------------------- How the Disciple became the Guru The Globalization of Innovation: Pharmaceuticals Skilled Immigrants and Economic Growth Education and Tech Entrepreneurship Getting the Numbers Right: International Engineering Education US-Based Global Intellectual Property Creation Intellectual Property, the Immigration Backlog, and a Reverse Brain Drain Education, Entrepreneurship and Immigration Where the Engineers Are America's New Immigrant Entrepreneurs Industry Trends in Engineering Offshoring Framing the Engineering Outsourcing Debate

Download Now

Multinational corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These relationships largely appear to be symbiotic. As a result of the movement of R&D to their countries, Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property. Several firms in India and China are performing advanced research and development and are moving into the highest-value segments of the pharmaceutical global value chain. What is noteworthy is that most of the advances in R&D in India and China happened over the last decade with the greatest momentum being built over the last five years.